Statins as potential therapeutic agents for healing disorders

References

• Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: transition from theory to practice. Circ. J.74(2), 213–220 (2010).
   PubMed Web of Science ®Google Scholar
• Brookes ZL, McGown CC, Reilly CS. Statins for all: the new premed? Br. J. Anaesth.103(1), 99–107 (2009).
   PubMed Web of Science ®Google Scholar
• Pasha MK, Muzeeb S, Basha SJ, Shashikumar D, Mullangi R, Srinivas NR. Analysis of five HMG-CoA reductase inhibitors – atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies. Biomed. Chromatogr.20(3), 282–293 (2006).
   PubMed Web of Science ®Google Scholar
• Ginter E, Simko V. Statins: the drugs for the 21st century? Bratisl. Lek. Listy110(10), 664–668 (2009).
   PubMed Web of Science ®Google Scholar
• Corsonello A, Garasto S, Abbatecola AM et al. Targeting inflammation to slow or delay functional decline: where are we? Biogerontology11(5), 603–614 (2010).
   PubMed Web of Science ®Google Scholar
• Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A. Drug-induced lupus erythematosus. Autoimmunity38(7), 507–518 (2005).
   PubMed Web of Science ®Google Scholar
• Pua VS, Scolyer RA, Barnetson RS. Pravastatin-induced lichenoid drug eruption. Australas. J. Dermatol.47(1), 57–59 (2006).
   PubMed Web of Science ®Google Scholar
• Gressier L, Pruvost-Balland C, Dubertret L, Viguier M. Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS). Ann. Dermatol. Venereol.136(1), 50–53 (2009).
   PubMed Web of Science ®Google Scholar
• Thual N, Penven K, Chevallier JM, Dompmartin A, Leroy D. Fluvastatin-induced dermatomyositis. Ann. Dermatol. Venereol.132(12 Pt 1), 996–999 (2005).
   PubMed Web of Science ®Google Scholar
• Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J. Clin. Invest. 117(5), 1219–1222 (2007).
   PubMed Web of Science ®Google Scholar
• Pastar I, Stojadinovic O, Tomic-Canic M. Role of keratinocytes in healing of chronic wounds. Surg. Technol. Int.17, 105–112 (2008).
   PubMedGoogle Scholar
• Vukelic S, Stojadinovic O, Pastar I et al. Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor. J. Biol. Chem.285(3), 1980–1988 (2010).
   PubMed Web of Science ®Google Scholar
• Guardamagna O, Abello F, Saracco P, Baracco V, Rolfo E, Pirro M. Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia. Atherosclerosis207(2), 471–475 (2009).
   PubMed Web of Science ®Google Scholar
• Proksch E, Elias PM, Feingold KR. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements. J. Clin. Invest.85(3), 874–882 (1990).
   PubMed Web of Science ®Google Scholar
• Kapiotis S, Holzer G, Schaller G et al. A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler. Thromb. Vasc. Biol.26(11), 2541–2546 (2006).
   PubMed Web of Science ®Google Scholar
• Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair. Regen.16(5), 585–601 (2008).
   PubMed Web of Science ®Google Scholar
• Jougasaki M, Ichiki T, Takenoshita Y, Setoguchi M. Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells. Br. J. Pharmacol.159(6), 1294–1303 (2010).
   PubMed Web of Science ®Google Scholar
• Singh P, Kohr D, Kaps M, Blaes F. Influence of statins on MHC class I expression. Ann. NY Acad. Sci.1173, 746–751 (2009).
   PubMed Web of Science ®Google Scholar
• Akasaki Y, Matsuda S, Nakayama K, Fukagawa S, Miura H, Iwamoto Y. Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation. Osteoarthritis Cartilage17(2), 235–243 (2009).
   PubMed Web of Science ®Google Scholar
• van der Most PJ, Dolga AM, Nijholt IM, Luiten PG, Eisel UL. Statins: mechanisms of neuroprotection. Prog. Neurobiol.88(1), 64–75 (2009).
   PubMed Web of Science ®Google Scholar
• Nezic L, Skrbic R, Dobric S et al. Simvastatin and indomethacin have similar anti-inflammatory activity in a rat model of acute local inflammation. Basic Clin. Pharmacol. Toxicol.104(3), 185–191 (2009).
   PubMed Web of Science ®Google Scholar
• Otuki MF, Pietrovski EF, Cabrini DA. Topical simvastatin: preclinical evidence for a treatment of skin inflammatory conditions. J. Dermatol. Sci.44(1), 45–47 (2006).
   PubMed Web of Science ®Google Scholar
• Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, Federman DG. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch. Dermatol.145(6), 700–703 (2009).
   PubMed Web of Science ®Google Scholar
• Brauser D. Statins added to standard psoriasis therapy may improve disease severity. Presented at: American Academy of Dermatology (AAD) 68th Annual Meeting. Miami, FL, USA, 5–10 March (2010).
   Google Scholar
• Toker S, Gulcan E, Cayc MK, Olgun EG, Erbilen E, Ozay Y. Topical atorvastatin in the treatment of diabetic wounds. Am. J. Med. Sci.338(3), 201–204 (2009).
   PubMed Web of Science ®Google Scholar
• Bitto A, Minutoli L, Altavilla D et al. Simvastatin enhances VEGF production and ameliorates impaired wound healing in experimental diabetes. Pharmacol. Res.57(2), 159–169 (2008).
   PubMed Web of Science ®Google Scholar
• Das S, Schapira M, Tomic-Canic M, Goyanka R, Cardozo T, Samuels HH. Farnesyl pyrophosphate is a novel transcriptional activator for a subset of nuclear hormone receptors. Mol. Endocrinol.21(11), 2672–2686 (2007).
   PubMedGoogle Scholar
• Gough N. Statins for wound healing. Sci. Signal3(105), ec24 (2010).
   Google Scholar
• Pauly S, Luttosch F, Morawski M, Haas NP, Schmidmaier G, Wildemann B. Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application. Bone45(3), 505–511 (2009).
   PubMed Web of Science ®Google Scholar
• Karadeniz Cakmak G, Irkorucu O, Ucan BH et al. Simvastatin improves wound strength after intestinal anastomosis in the rat. J. Gastrointest. Surg.13(9), 1707–1716 (2009).
   PubMed Web of Science ®Google Scholar
• Falanga V. Wound healing and its impairment in the diabetic foot. Lancet366(9498), 1736–1743 (2005).
   PubMed Web of Science ®Google Scholar
• Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J et al. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J. Clin. Invest.101(12), 2711–2719 (1998).
   PubMed Web of Science ®Google Scholar
• Van der Harst P, Wagenaar LJ, Buikema H et al. Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease. Am. J. Cardiol.96(10), 1361–1364 (2005).
   PubMed Web of Science ®Google Scholar
• Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J. Biol. Chem.273(37), 24266–24271 (1998).
   PubMed Web of Science ®Google Scholar
• Mital S, Zhang X, Zhao G et al. Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogs. Am. J. Physiol. Heart Circ. Physiol.279(6), H2649–H2657 (2000).
   Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Adler K et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation103(24), 2885–2890 (2001).
   PubMed Web of Science ®Google Scholar
• Kureishi Y, Luo Z, Shiojima I et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat. Med.6(9), 1004–1010 (2000).
   PubMed Web of Science ®Google Scholar
• Fujii T, Onimaru M, Yonemitsu Y, Kuwano H, Sueishi K. Statins restore ischemic limb blood flow in diabetic microangiopathy via eNOS/NO upregulation but not via PDGF-BB expression. Am. J. Physiol. Heart Circ. Physiol.294(6), H2785–H2791 (2008).
   Google Scholar
• Thangarajah H, Yao D, Chang EI et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc. Natl Acad. Sci. USA106(32), 13505–13510 (2009).
   PubMed Web of Science ®Google Scholar
• Brem H, Kodra A, Golinko MS et al. Mechanism of sustained release of vascular endothelial growth factor in accelerating experimental diabetic healing. J. Invest. Dermatol.129(9), 2275–2287 (2009).
   PubMed Web of Science ®Google Scholar
• Weis M, Heeschen C, Glassford AJ, Cooke JP. Statins have biphasic effects on angiogenesis. Circulation105(6), 739–745 (2002).
   PubMed Web of Science ®Google Scholar
• Park KW, Hwang KK, Cho HJ et al. Simvastatin enhances endothelial differentiation of peripheral blood mononuclear cells in hypercholesterolemic patients and induces pro-angiogenic cytokine IL-8 secretion from monocytes. Clin. Chim. Acta388(1–2), 156–166 (2008).
   PubMed Web of Science ®Google Scholar
• Giurgea AG, Margeta C, Maca T et al. Simvastatin reduces serum level of vascular endothelial growth factor in hypercholesterolemic patients. J. Cardiovasc. Pharmacol.47(1), 30–36 (2006).
   PubMed Web of Science ®Google Scholar
• Park HJ, Kong D, Iruela-Arispe L, Begley U, Tang D, Galper JB. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ. Res.91(2), 143–150 (2002).
   PubMed Web of Science ®Google Scholar
• Schiefelbein D, Goren I, Fisslthaler B et al. Biphasic regulation of HMG-CoA reductase expression and activity during wound healing and its functional role in the control of keratinocyte angiogenic and proliferative responses. J. Biol. Chem.283(22), 15479–15490 (2008).
   PubMed Web of Science ®Google Scholar
• Johansen O, Birkeland K, Jorgensen A et al. Diabetic foot ulcer burden may be modified by high- dose atorvastatin: a 6-month randomized controlled pilot trial. J. Diabetes1, 182–187 (2009).
   PubMed Web of Science ®Google Scholar
• Kuwana M, Kaburaki J, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y. Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis. Arthritis Rheum.54(6), 1946–1951 (2006).
   PubMed Web of Science ®Google Scholar
• Davis TM, Yeap BB, Davis WA, Bruce DG. Lipid-lowering therapy and peripheral sensory neuropathy in Type 2 diabetes: the Fremantle Diabetes Study. Diabetologia51(4), 562–566 (2008).
   PubMed Web of Science ®Google Scholar
• Nyman JS, Munoz S, Jadhav S et al. Quantitative measures of femoral fracture repair in rats derived by micro-computed tomography. J. Biomech.42(7), 891–897 (2009).
   PubMed Web of Science ®Google Scholar
• Wang JW, Xu SW, Yang DS, Lv RK. Locally applied simvastatin promotes fracture healing in ovariectomized rat. Osteoporos. Int.18(12), 1641–1650 (2007).
   PubMed Web of Science ®Google Scholar
• Gutierrez GE, Edwards JR, Garrett IR et al. Transdermal lovastatin enhances fracture repair in rats. J. Bone Miner. Res.23(11), 1722–1730 (2008).
   PubMed Web of Science ®Google Scholar
• Mundy G, Garrett R, Harris S et al. Stimulation of bone formation in vitro and in rodents by statins. Science286(5446), 1946–1949 (1999).
   PubMed Web of Science ®Google Scholar
• Nyan M, Miyahara T, Noritake K et al. Molecular and tissue responses in the healing of rat calvarial defects after local application of simvastatin combined with a tricalcium phosphate. J. Biomed. Mater. Res. B Appl. Biomater.93(1), 65–73 (2010).
   PubMedGoogle Scholar
• Luisetto G, Camozzi V. Statins, fracture risk, and bone remodeling. J. Endocrinol. Invest.32(4 Suppl.), 32–37 (2009).
   PubMedGoogle Scholar
• Ayukawa Y, Yasukawa E, Moriyama Y et al. Local application of statin promotes bone repair through the suppression of osteoclasts and the enhancement of osteoblasts at bone-healing sites in rats. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.107(3), 336–342 (2009).
   PubMed Web of Science ®Google Scholar
• Moriyama Y, Ayukawa Y, Ogino Y, Atsuta I, Koyano K. Topical application of statin affects bone healing around implants. Clin. Oral Implants Res.19(6), 600–605 (2008).
   PubMed Web of Science ®Google Scholar
• Patil S, Holt G, Raby N et al. Prospective, double blind, randomized, controlled trial of simvastatin in human fracture healing. J. Orthop. Res.27(3), 281–285 (2009).
   PubMed Web of Science ®Google Scholar
• Skoglund B, Aspenberg P. Locally applied simvastatin improves fracture healing in mice. BMC Musculoskelet. Disord.8, 98 (2007).
   PubMed Web of Science ®Google Scholar
• Garrett IR, Gutierrez GE, Rossini G et al. Locally delivered lovastatin nanoparticles enhance fracture healing in rats. J. Orthop. Res.25(10), 1351–1357 (2007).
   PubMed Web of Science ®Google Scholar
• Chissas D, Stamatopoulos G, Verettas D et al. Can low doses of simvastatin enhance fracture healing? An experimental study in rabbits. Injury41(7), 761–766 (2010).
   Google Scholar
• Tleyjeh IM, Kashour T, Hakim FA et al. Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch. Intern. Med.169(18), 1658–1667 (2009).
   PubMed Web of Science ®Google Scholar
• Dobesh PP, Klepser DG, McGuire TR, Morgan CW, Olsen KM. Reduction in mortality associated with statin therapy in patients with severe sepsis. Pharmacotherapy29(6), 621–630 (2009).
   PubMed Web of Science ®Google Scholar
• Donnino MW, Cocchi MN, Howell M et al. Statin therapy is associated with decreased mortality in patients with infection. Acad. Emerg. Med.16(3), 230–234 (2009).
   PubMed Web of Science ®Google Scholar
• Jerwood S, Cohen J. Unexpected antimicrobial effect of statins. J. Antimicrob. Chemother.61(2), 362–364 (2008).
   PubMed Web of Science ®Google Scholar
• Merx MW, Liehn EA, Graf J et al. Statin treatment after onset of sepsis in a murine model improves survival. Circulation112(1), 117–124 (2005).
   PubMed Web of Science ®Google Scholar
• Merx MW, Liehn EA, Janssens U et al. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation109(21), 2560–2565 (2004).
   PubMed Web of Science ®Google Scholar
• Kruger P, Fitzsimmons K, Cook D, Jones M, Nimmo G. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med.32(1), 75–79 (2006).
   PubMed Web of Science ®Google Scholar
• Rego AC, Araújo Filho I, Damasceno BP et al. Simvastatin improves the healing of infected skin wounds of rats. Acta. Cir. Bras.22(Suppl. 1), 57–63 (2007).
   PubMed Web of Science ®Google Scholar
• Friesen JA, Rodwell VW. The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases. Genome Biol.5(11), 248 (2004).
   PubMed Web of Science ®Google Scholar
• Pentikainen PJ, Saraheimo M, Schwartz JI et al. Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans. J. Clin. Pharmacol.32(2), 136–140 (1992).
   PubMed Web of Science ®Google Scholar
• Weber MS, Zamvil SS. Statins and demyelination. Curr. Top. Microbiol. Immunol.318, 313–324 (2008).
   PubMed Web of Science ®Google Scholar
• Lahera V, Goicoechea M, de Vinuesa SG et al. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Curr. Med. Chem.14(2), 243–248 (2007).
   PubMed Web of Science ®Google Scholar
• Serin-Kilicoglu S, Erdemli E. New addition to the statin’s effect. J. Trauma63(1), 187–191 (2007).
   PubMed Web of Science ®Google Scholar
• Ko J, Zhao Y, Hong S et al. HMG-CoA reductase inhibitors (statins) reduce hypertrophic scar formation in a rabbit ear wounding model. Presented at: Symposium on Advanced Wound Care and Wound Healing Society Meeting. Orlando, FL, USA, 17–20 April (2010).
   Google Scholar
• Meyer-Ter-Vehn T, Katzenberger B, Han H, Grehn F, Schlunck G. Lovastatin inhibits TGF-β-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest. Ophthalmol. Vis. Sci.49(9), 3955–3960 (2008).
   PubMed Web of Science ®Google Scholar
• Kuznia P, Lewin A, Schultz G. Effects of simvastatin on transforming growth factor beta induced connective tissue growth factor protein expression levels in human corneal fibroblasts. Presented at: Symposium on Advanced Wound Care and Wound Healing Society Meeting. Orlando, FL, USA, 17–20 April (2010).
   Google Scholar
• Evers BM, Farooqi MS, Shelton JM et al. Hair growth defects in Insig-deficient mice caused by cholesterol precursor accumulation and reversed by simvastatin. J. Invest. Dermatol.130(5), 1237–1248 (2010).
   PubMed Web of Science ®Google Scholar